Barclays PLC Ani Pharmaceuticals Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Barclays PLC holds 143,033 shares of ANIP stock, worth $7.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

143,033

Previous 143,033 -0.0%

Holding current value

$7.75 Million

Previous $8.53 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$54.33 - $65.72 $7.33 Million - $8.87 Million	135,003 Added 1681.23%	143,033 $8.53 Million
Q2 2024 Aug 14, 2024	SELL	$58.53 - $68.82 $401,047 - $471,554	-6,852 Reduced 46.04%	8,030 $511,000
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $562,758 - $723,591	-10,383 Reduced 41.1%	14,882 $1.03 Million
Q4 2023 Feb 15, 2024	BUY	$48.72 - $65.43 $776,791 - $1.04 Million	15,944 Added 171.05%	25,265 $1.39 Million
Q3 2023 Nov 07, 2023	BUY	$50.28 - $64.61 $84,570 - $108,674	1,682 Added 22.02%	9,321 $541,000
Q2 2023 Aug 03, 2023	BUY	$37.29 - $53.83 $18,570 - $26,807	498 Added 6.97%	7,639 $411,000
Q1 2023 May 04, 2023	BUY	$37.61 - $45.72 $22,377 - $27,203	595 Added 9.09%	7,141 $283,000
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $69,956 - $91,996	2,193 Added 50.38%	6,546 $264,000
Q3 2022 Nov 03, 2022	SELL	$29.83 - $38.01 $89,460 - $113,991	-2,999 Reduced 40.79%	4,353 $140,000
Q2 2022 Aug 12, 2022	SELL	$23.09 - $33.46 $102,981 - $149,231	-4,460 Reduced 37.76%	7,352 $218,000
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $111,784 - $195,861	-4,154 Reduced 26.02%	11,812 $331,000
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $270,024 - $465,601	8,190 Added 105.32%	15,966 $736,000
Q3 2021 Nov 09, 2021	BUY	$26.48 - $35.99 $66,862 - $90,874	2,525 Added 48.09%	7,776 $255,000
Q2 2021 Aug 13, 2021	SELL	$31.86 - $38.6 $362,088 - $438,689	-11,365 Reduced 68.4%	5,251 $185,000
Q1 2021 May 13, 2021	BUY	$28.4 - $36.14 $34,932 - $44,452	1,230 Added 7.99%	16,616 $601,000
Q4 2020 Feb 11, 2021	SELL	$23.69 - $31.47 $23,571 - $31,312	-995 Reduced 6.07%	15,386 $447,000
Q3 2020 Nov 12, 2020	BUY	$26.38 - $33.1 $78,823 - $98,902	2,988 Added 22.31%	16,381 $462,000
Q2 2020 Aug 12, 2020	BUY	$29.93 - $50.1 $27,415 - $45,891	916 Added 7.34%	13,393 $433,000
Q1 2020 May 13, 2020	SELL	$30.35 - $67.14 $40,547 - $89,699	-1,336 Reduced 9.67%	12,477 $509,000
Q4 2019 Feb 10, 2020	BUY	$55.65 - $79.83 $257,436 - $369,293	4,626 Added 50.35%	13,813 $852,000
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $211,892 - $279,652	-3,275 Reduced 26.28%	9,187 $669,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $776,169 - $941,436	-11,453 Reduced 47.89%	12,462 $1.02 Million
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $12,282 - $18,904	-268 Reduced 1.11%	23,915 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $363,695 - $498,590	8,834 Added 57.55%	24,183 $1.09 Million
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $284,923 - $383,880	5,381 Added 53.98%	15,349 $868,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $72,842 - $87,959	-1,292 Reduced 11.47%	9,968 $665,000
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $39,031 - $49,600	685 Added 6.48%	11,260 $655,000
Q4 2017 Feb 14, 2018	BUY	$53.3 - $74.56 $198,009 - $276,990	3,715 Added 54.15%	10,575 $681,000
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $298,135 - $360,081	6,860	6,860 $361,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.7M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $944M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account